Posted on July 22, 20257/22/25
Case Study: Transforming Market Access with NAVLIN Insights KPI
Posted on July 8, 20257/8/25
Navigating the Not-So-Direct Path to Access – A Pharmacist’s Perspective
Posted on May 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on April 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on September 30, 20249/30/24
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
Posted on September 13, 20249/13/24
Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets
Posted on July 22, 20247/22/24
AI’s Role in Drug Launches, Operations, and Drug Pricing: Q&A with Abid Rahman
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on May 13, 20245/13/24